EKF Diagnostics, a global medical diagnostics business, is showcasing its products and services at Medlab Middle East 2023 in Dubai between 6-9 February.
EKF delivers diagnostic technologies and biotechnology solutions that empower healthcare and medical providers to make informed clinical decisions through point-of-care testing and life sciences applications.
The EKF portfolio of products and services supports several key areas of healthcare including hematology, diabetes, women’s health, sports performance, pathology, clinical research, laboratory testing, and contract manufacturing.
Products being presented and demonstrated at the event include:
- Hemo Control – Accurate hemoglobin and hematocrit results with one simple test
- DiaSpect Tm – Immediate hemoglobin results from a hand-held analyzer
- Quo-Lab® – A revolution in HbA1c measurement at the point-of-care
- EKF Link – Enables the management of point-of-care analyzers and data on one centralized platform
The EKF Diagnostics booth can be found at Z2.B28, with presentations at the event by:
- Steven Wray – EMEA Sales Director
- Rajneesh Mahajan – Business Head – India & SAARC Countries Sales
- Richard Park – Regional Sales Manager
- Paul Asmar – Regional Sales Manager for Middle East and Africa
- William Shorter – Global Product Manager – Diabetes Care
Medlab Middle East
- Now in its 22nd year, Medlab Middle East plays a crucial role in developing the value of laboratory medicine by transforming tomorrow’s diagnostics and enabling industry peers and professionals to come together and network.
- www.medlabme.com